Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial.

Nikhil Seval, Johnathan Nunez,Prerana Roth,Meredith Schade, Michelle Strong,Cynthia A Frank,Alain H Litwin,Frances R Levin,Kathleen T Brady,Edward V Nunes,Sandra A Springer

Journal of addiction medicine（2023）

引用 1|浏览10

暂无评分

摘要

Inpatient low-dose buprenorphine transition from full agonist opioids including methadone onto LAB is feasible even in those with complex hospitalizations for concurrent infections and/or surgery. This strategy facilitates dosing of LAB before hospital discharge when risk of opioid relapse and overdose are significant.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要